🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 96-week extension study of open-label simufilam 100 mg b.i.d. for...
Status
Terminated
Location
Cognitive Clinical Trials
Start Date
2022-05-12
Trial ID
NCT05352763
Treatments Being Tested
A 52-week safety and efficacy study of simufilam (PTI-125) given twice dail...
Status
Completed
Location
MDFirst Research
Start Date
2021-11-03
Trial ID
NCT04994483
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2017-08-18
Trial ID
NCT03784300
Treatments Being Tested
A 76-week safety and efficacy study of simufilam (PTI-125) given twice dail...
Status
Terminated
Location
Banner Alzheimer's Institute
Start Date
2021-11-18
Trial ID
NCT05026177
The goal of this open-label extension study is to assess long-term safety a...
Status
Terminated
Location
MDFirst Research
Start Date
2022-11-07
Trial ID
NCT05575076
Treatments Being Tested
Evaluate simufilam levels in the blood of hepatically impaired individuals ...
Status
Completed
Location
Orange County Research Center
Start Date
2024-06-26
Trial ID
NCT06390410
Treatments Being Tested
This is a Phase 2b, Randomized, Double-blind, Placebo-controlled, multiple ...
Status
Completed
Location
Cognitive Clinical Trials
Start Date
2019-09-09
Trial ID
NCT04079803
Treatments Being Tested
A two-year safety study of simufilam (PTI-125) 100 mg oral tablets twice da...
Status
Completed
Location
Cognitive Clinical Trials
Start Date
2020-03-24
Trial ID
NCT04388254
Treatments Being Tested
This study will compare the pharmacokinetics of the Phase 3 simufilam 100 m...
Status
Completed
Location
Worldwide Clinical Trials Phase I Unit
Start Date
2021-05-04
Trial ID
NCT04932655
Treatments Being Tested
This is a Phase 2a, multi-center, open-label study of PTI-125 in mild-to-mo...
Status
Completed
Location
Insite Clinical Research
Start Date
2019-03-07
Trial ID
NCT03748706
Treatments Being Tested